Catalyst Wire Dossier Catalyst Wire Dossier

F511 Cream

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F511 Cream, covering 2019-05-15 to 2019-05-15. Get the full timeline:

Most recent: Clinical Trial Update: F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer [Phase 3]

See pricing